Lupin Pharmaceuticals Inc. has recalled 39,216 bottles of Lisinopril and Hydrochlorothiazide (10 mg/12.5 mg) tablets, a prescription medication used to treat high blood pressure. This recall was initiated after reports of brownish or blackish stains on the tablets themselves and a similar dark powder found inside the bottles. Consumers are advised to check their medication bottles for specific batch number H900575 and contact their healthcare provider immediately for guidance.
The presence of an unknown foreign substance, identified as brownish or blackish stains and powder, poses a risk of contamination which could lead to adverse health effects or reduced drug effectiveness. While no specific injuries have been reported, the contamination indicates a quality failure that may compromise patient safety.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.